156 related articles for article (PubMed ID: 16632427)
1. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma.
García JR; Simo M; Huguet M; Ysamat M; Lomeña F
Clin Transl Oncol; 2006 Feb; 8(2):124-8. PubMed ID: 16632427
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging of renal vein and inferior vena cava tumor thrombus from renal cell carcinoma.
Nguyen BD
Clin Nucl Med; 2005 Feb; 30(2):107-9. PubMed ID: 15647678
[No Abstract] [Full Text] [Related]
3. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
5. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
6. Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography--a preliminary report.
Chang CH; Shiau YC; Shen YY; Kao A; Lin CC; Lee CC
Urol Int; 2003; 71(3):306-9. PubMed ID: 14512653
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of
Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
[TBL] [Abstract][Full Text] [Related]
8. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
10. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
[TBL] [Abstract][Full Text] [Related]
11.
Cao J; Yang Y
J Nucl Cardiol; 2021 Dec; 28(6):3085-3087. PubMed ID: 33977368
[No Abstract] [Full Text] [Related]
12. FDG uptake in tumor thrombus in inferior vena cava from rectal cancer on positron emission tomography.
Gupta P; Kramer EL; Ponzo F
Clin Nucl Med; 2005 May; 30(5):342-3. PubMed ID: 15827409
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W
Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma.
Ozturk H
Minerva Urol Nefrol; 2016 Jun; 68(3):263-9. PubMed ID: 25916217
[TBL] [Abstract][Full Text] [Related]
15. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
16. FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography.
Sizemore AW; Jacobs MP; Mantil JC; Hahm GK
Clin Nucl Med; 2007 Apr; 32(4):309-11. PubMed ID: 17413583
[No Abstract] [Full Text] [Related]
17. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular myocardium metastasis in a patient with primary renal cell carcinoma detected by 18F-FDG PET/CT.
Pinnamaneni N; Muthukrishnan A
Clin Nucl Med; 2012 Jul; 37(7):e181-3. PubMed ID: 22691531
[TBL] [Abstract][Full Text] [Related]
19. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Alongi P; Picchio M; Zattoni F; Spallino M; Gianolli L; Saladini G; Evangelista L
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of
Zhu AH; Hou XY; Tian S; Zhang WF
Sci Rep; 2022 Jan; 12(1):587. PubMed ID: 35022440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
